Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and Medicine.
作者信息
Mandelblatt J S, Fryback D G, Weinstein M C, Russell L B, Gold M R
机构信息
Georgetown University School of Medicine, Lombardi Cancer Center, Washington, DC 20007, USA.
出版信息
J Gen Intern Med. 1997 Sep;12(9):551-8. doi: 10.1046/j.1525-1497.1997.07107.x.
Abstract
摘要
相似文献
1
Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and Medicine.评估卫生干预措施在成本效益分析中的有效性。卫生与医学成本效益小组。
J Gen Intern Med. 1997 Sep;12(9):551-8. doi: 10.1046/j.1525-1497.1997.07107.x.
2
In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care.探寻力量与意义：医疗保健领域随机成本效益研究的设计与分析问题
Med Care. 1994 Feb;32(2):150-63. doi: 10.1097/00005650-199402000-00006.
3
Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.成本效益比的置信区间：菲勒定理的一个应用。
Health Econ. 1996 Jul-Aug;5(4):297-305. doi: 10.1002/(SICI)1099-1050(199607)5:4<297::AID-HEC216>3.0.CO;2-T.
4
Cost-effectiveness analysis in heart disease, Part I: General principles.心脏病的成本效益分析，第一部分：一般原则。
Prog Cardiovasc Dis. 1994 Nov-Dec;37(3):161-84. doi: 10.1016/s0033-0620(05)80041-6.
5
Understanding cost data collection tools to improve economic evaluations of health interventions.理解成本数据收集工具，以改善健康干预措施的经济评估。
Stroke Vasc Neurol. 2019 Dec 1;4(4):214-222. doi: 10.1136/svn-2019-000301. eCollection 2019 Dec.
6
A Bayesian approach to stochastic cost-effectiveness analysis.一种用于随机成本效益分析的贝叶斯方法。
Health Econ. 1999 May;8(3):257-61. doi: 10.1002/(sici)1099-1050(199905)8:3<257::aid-hec427>3.0.co;2-e.
7
Cost-effectiveness and cost-benefit analysis of health services: the methodology and its application.卫生服务的成本效益与成本效益分析：方法及其应用
Health Policy. 1988;9(3):251-65. doi: 10.1016/0168-8510(88)90013-9.
8
Can economics be bad for your health?经济状况会对你的健康有害吗？
Health Care Anal. 1997 Dec;5(4):299-305. doi: 10.1007/BF02678528.
9
A bootstrap approach to medical decision analysis.一种用于医学决策分析的自助法。
J Health Econ. 1997 Dec;16(6):741-7. doi: 10.1016/s0167-6296(97)00002-7.
10
The future of health economic modeling: have we gone too far or not far enough?健康经济模型的未来：我们是否走得太远或还不够远？
Value Health. 2006 May-Jun;9(3):179-80. doi: 10.1111/j.1524-4733.2006.00115.x.
引用本文的文献
1
Modelling the cost-effectiveness of cervical cancer screening with HPV self-sampling and molecular triage for women aged 60-69 years.对60至69岁女性采用人乳头瘤病毒（HPV）自我采样和分子分流进行宫颈癌筛查的成本效益建模。
Discov Oncol. 2025 May 18;16(1):805. doi: 10.1007/s12672-025-02432-3.
2
Bibliometric study on scientific productivity in the use of smart bracelets.关于智能手环使用方面科研产出的文献计量学研究
Eur J Transl Myol. 2023 Oct 10;33(4):11572. doi: 10.4081/ejtm.2023.11572.
3
Restructuring lung cancer care to accelerate diagnosis and treatment in patients vulnerable to healthcare disparities using an innovative care model.采用创新护理模式重组肺癌护理，以加速对易受医疗保健差异影响的患者的诊断和治疗。
MethodsX. 2023 Aug 24;11:102338. doi: 10.1016/j.mex.2023.102338. eCollection 2023 Dec.
4
Costs and models used in the economic analysis of Total Knee Replacement (TKR): A systematic review.全膝关节置换术（TKR）经济分析中使用的成本和模型：系统评价。
PLoS One. 2023 Jul 25;18(7):e0280371. doi: 10.1371/journal.pone.0280371. eCollection 2023.
5
The Integration of Clinical Decision Support Systems Into Telemedicine for Patients With Multimorbidity in Primary Care Settings: Scoping Review.将临床决策支持系统整合到初级保健环境中患有多种疾病的远程医疗患者中：范围综述。
J Med Internet Res. 2023 Jun 28;25:e45944. doi: 10.2196/45944.
6
Cost-effectiveness of the combination of immunotherapy and chemotherapy for extensive-stage small-cell lung cancer: a systematic review.免疫治疗联合化疗治疗广泛期小细胞肺癌的成本效果分析：系统评价
BMC Health Serv Res. 2023 Jun 26;23(1):691. doi: 10.1186/s12913-023-09727-7.
7
A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R.一种简单的筛查成本效益模型：用R语言编写的开源教学与研究工具。
Pharmacoecon Open. 2023 Jul;7(4):507-523. doi: 10.1007/s41669-023-00414-1. Epub 2023 Jun 1.
8
Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models.癌症干预和监测建模网络 (CISNET) 乳腺癌模型简介。
Med Decis Making. 2018 Apr;38(1_suppl):3S-8S. doi: 10.1177/0272989X17737507.
9
Disability-adjusted Life Years (DALYs) for Mental and Substance Use Disorders in the Korean Burden of Disease Study 2012.《2012年韩国疾病负担研究中精神和物质使用障碍的伤残调整生命年》
J Korean Med Sci. 2016 Nov;31 Suppl 2(Suppl 2):S191-S199. doi: 10.3346/jkms.2016.31.S2.S191.
10
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.美国不同乳腺癌筛查策略相关获益与危害的协同建模
Ann Intern Med. 2016 Feb 16;164(4):215-25. doi: 10.7326/M15-1536. Epub 2016 Jan 12.
本文引用的文献
1
A Markov model of early diagnosis.早期诊断的马尔可夫模型
Acad Radiol. 1996 Apr;3 Suppl 1:S10-2. doi: 10.1016/s1076-6332(96)80467-3.
2
Case-control evaluation of screening.筛查的病例对照评估
J Clin Epidemiol. 1996 Mar;49(3):390-1; author reply 391-2. doi: 10.1016/0895-4356(95)00575-7.
3
4
Noncancer deaths in white adult cancer patients.成年白人癌症患者的非癌症死亡情况。
J Natl Cancer Inst. 1993 Jun 16;85(12):979-87. doi: 10.1093/jnci/85.12.979.
5
Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.诊断成像技术的进步以及对疾病患病率和治疗益处的高估。
N Engl J Med. 1993 Apr 29;328(17):1237-43. doi: 10.1056/NEJM199304293281706.
6
Cost-effectiveness of a routine varicella vaccination program for US children.美国儿童常规水痘疫苗接种计划的成本效益
JAMA. 1994 Feb 2;271(5):375-81.
7
Markov models in medical decision making: a practical guide.医学决策中的马尔可夫模型：实用指南。
Med Decis Making. 1993 Oct-Dec;13(4):322-38. doi: 10.1177/0272989X9301300409.
8
Decision analysis: introductory lectures on choices under uncertainty. 1968.决策分析：不确定性下选择的入门讲座。1968年。
MD Comput. 1993 Sep-Oct;10(5):312-28.
9
Using Medicare claims for outcomes research.利用医疗保险理赔数据进行结果研究。
Med Care. 1994 Jul;32(7 Suppl):JS38-51.
10
Selection bias in observational and experimental studies.观察性研究和实验性研究中的选择偏倚。
Stat Med. 1994;13(5-7):557-67. doi: 10.1002/sim.4780130518.
Zotero 插件